Skip to main content

Table 3 Laboratory data of COVID-19 patients included in the study

From: Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt

 

Cases with available data

All patients

Patients without comorbidity

Patients with comorbidities

P-value

CBC

Hemoglobin (g/dl)

393

12.2 ± 2.0

12.6 ± 1.9

11.9 ± 2.0

0.001

 Anemic (HB < 12)

178 (45.3%)

54 (35.8%)

124 (51.2%)

0.003

WBCs (103/ul)

405

9.2 ± 5.5

8.3 ± 4.8

9.8 ± 5.9

0.003

 Low (< 4)

46 (11.4%)

23 (14.8%)

21 (9.2%)

0.014

 High (> 10)

143 (35.3%)

42 (27.1%)

101 (40.4%)

Neutrophil (%)

315

68.1 ± 20.4

63.5 ± 20.9

70.5 ± 19.7

0.013

 Low (< 40)

26 (8.3%)

13 (11.8%)

13 (6.3%)

0.029

 High (> 75)

144 (45.7%)

40 (36.4%)

104 (50.7%)

Lymphocytes (%)

407

19.9 ± 14.6

23.0 ± 15.6

18.1 ± 13.7

0.001

 Low (< 20)

242 (59.8%)

82 (53.6%)

160 (63.5%)

0.085

Lymphocytes (103/ul)

407

1.4 ± 0.98

1.5 ± 0.99

1.4 ± 0.98

0.301

 Low (< 1.5)

256 (62.9%)

92 (59.7%)

164 (64.8%)

0.542

Platelets (103/ul)

391

275.2 ± 139.1

283.9 ± 118.7

269.8 ± 150.5

0.177

 Low (< 140)

37 (9.5%)

4 (2.7%)

33 (13.7%)

 < 0.001

 High (> 450)

37 (9.5%)

10 (6.7%)

27 (11.2%)

INR

256

1.1 ± 0.32

1.0 ± 0.12

1.1 ± 0.39

0.092

Ferritin (ng/ml)

262

749.0 ± 997.4

698.9 ± 1137.5

777.9 ± 909.0

0.002

 High (> 291)

165 (63%)

50 (52.1%)

115 (69.3%)

0.005

d-dimer (mg/l)

297

2.5 ± 8.7

1.3 ± 3.4

3.5 ± 11.1

 < 0.001

 High (> 0.55)

180 (60.6%)

53 (41.7%)

127 (74.7%)

 < 0.001

CRP (mg/dl)

289

57.8 ± 74.1

43.0 ± 74.5

68.3 ± 72.2

 < 0.001

 High (> 1)

282 (97.6%)

114 (95%)

168 (99.4%)

0.016

PCR

 Positive

416

354 (85.1%)

144 (88.9%)

210 (82.7%)

0.083

 Negative

43 (10.6%)

18 (11.1%)

44 (17.3%)

  1. CBC: complete blood picture; WBCs: white blood cells; INR: international normalized ratio; PCR: polymerase chain reaction